Macimorelin acetate (brand name Macrilen in the US, Ghryvelin in Europe) is an oral diagnostic agent used to assess adult growth hormone deficiency (AGHD). It is not a treatment but a testing tool. It is grouped under the following drug class(es): Peptides. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include ARD-07 ACETATE, EP-1572 ACETATE and Macrilen. Its PubChem CID is 71526737.
Macimorelin acetate
| CAS No | 945212-59-9 |
|---|---|
| Molecular Formula | C28H34N6O5 |
| Molecular Weight | 534.60 g/mol |
| Synonyms | acetic acid;2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Macimorelin acetate (brand name Macrilen in the US, Ghryvelin in Europe) is an oral diagnostic agent used to assess adult growth hormone deficiency (AGHD). It is not a treatment but a testing tool.
The listed CAS number is 945212-59-9.
The listed molecular formula is C28H34N6O5.
The listed molecular weight is 534.60 g/mol.
acetic acid;2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide.
The source lists ARD-07 ACETATE, EP-1572 ACETATE and Macrilen.